Investor Information: 2010 Press Releases

Receive E-mail AlertsE-mail Alerts
Keyword Search
 
2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008
DateTitle 
11/16/10PhotoMedex Launches New Patient-Focused XTRAC Laser Website
Design focuses on Company's commitment to Direct-To-Consumer Marketing Efforts MONTGOMERYVILLE, Pa., Nov. 16, 2010 /PRNewswire via COMTEX/ --PhotoMedex, Inc. (Nasdaq: PHMD), a global skin health medical technology company, announced today the launch of its newly designed and engineered website. The new site, www.XTRACLASER.com, introduces and integrates a strong educational component, as well as a valuable support system for our physician partners and their patients. PhotoMedex is a glob... 
Printer Friendly Version
10/28/10PhotoMedex NEOVA(R) DNA Total Repair Featured on 'THE Doctors'
MONTGOMERYVILLE, Pa., Oct 28, 2010 /PRNewswire via COMTEX/ --DNA Total Repair, the hero product of the NEOVA(R) skincare brand by PhotoMedex, Inc. (Nasdaq: PHMD), a leading supplier of advanced, clinical skincare and medical laser products for nearly a decade, was featured in the October 27th episode of "THE Doctors," the popular national daytime show that offers viewers reliable and fascinating medical and health advice, dispensed by a distinguished panel of "on-call" professionals. The th... 
Printer Friendly Version
09/15/10Neova(R) Launches DNA + Copper Combination Therapy Products in National and International Markets
Breakthrough Technology Revolutionizes the Repair of Photodamage MONTGOMERYVILLE, Pa., Sept 15, 2010 /PRNewswire via COMTEX/ --PhotoMedex, Inc. (Nasdaq: PHMD) a leading supplier of advanced, clinical skincare and medical laser products for nearly a decade, today announced the introduction of its DNA + Copper[Cu]product line, formulated and marketed by the company's Neova(R) brand. Neova DNA + Cu Combination Therapy products use cutting edge technologies to address DNA damage by activatin... 
Printer Friendly Version
07/08/10PhotoMedex Receives Purchase Order from Its Middle East Distributor for Seventy-Five XTRAC(R) Laser Systems
MONTGOMERYVILLE, Pa., Jul 08, 2010 (BUSINESS WIRE) -- PhotoMedex, Inc. (Nasdaq:PHMD) announced that the Company has received from AMICO Group, its distributor in the Middle East, a multi-million dollar order to purchase XTRAC laser systems that will be installed in hospitals throughout the Kingdom of Saudi Arabia. The order includes customary terms and conditions, including advanced payments and letters of credit covering the purchase order. Delivery is expected to be in the third and fourth q... 
Printer Friendly Version
06/07/10PhotoMedexAnnounces Clinical Trial Using the XTRAC Velocity(R)Laser in the Treatment of Severe Generalized Psoriasis
MONTGOMERYVILLE, Pa., Jun 07, 2010 (BUSINESS WIRE) --PhotoMedex, Inc. (Nasdaq: PHMD) announced today that John Koo, MD will be the principal investigator in a clinical study assessing the efficacy of the XTRAC Velocity(R) excimer laser in the treatment of generalized psoriasis when used in combination with Clobex(R) spray. Dr. Koo is Professor and Vice Chairman in the Department of Dermatology at the University of California San Francisco Medical Center. S... 
Printer Friendly Version
06/01/10PhotoMedex Appoints James Sight and Paul Denby to the Board of Directors
MONTGOMERYVILLE, Pa., Jun 01, 2010 (BUSINESS WIRE) --PhotoMedex, Inc. (Nasdaq: PHMD) announced today the appointment of James W. Sight and Paul J. Denby to its Board of Directors. Mr. Sight will serve as Vice Chairman of the Board of PhotoMedex. Mr. Sight, an investor serving on the board of directors of various other public companies, has over 20 years of experience in corporate restructurings and financings. He currently serves in the office of the Pr... 
Printer Friendly Version
05/07/10PhotoMedexAnnounces Closing of Public Offering of Common Stock
MONTGOMERYVILLE, Pa., May 07, 2010 (BUSINESS WIRE) --PhotoMedex, Inc. (Nasdaq: PHMD) (the "Company") announced today that it has closed on an underwritten public offering of 534,000 shares of its common stock at a price to the public of $6.00 per share for gross proceeds of $3,204,000. The underwriters exercised their over-allotment option for 34,000 shares. The proceeds of the offering will be used for general working capital and other corporate purpos... 
Printer Friendly Version
05/04/10PhotoMedexAnnounces Pricing of Public Offering of Common Stock
MONTGOMERYVILLE, Pa., May 04, 2010 (BUSINESS WIRE) --PhotoMedex, Inc. (Nasdaq:PHMD) (the "Company") announced today that it has priced an underwritten public offering of 500,000 shares of its common stock at a price to the public of $6.00 per share for gross proceeds of $3,000,000. The offering is expected to settle and close on May 7, 2010, subject to customary closing conditions. The Company has granted the underwriters a 45-day option to purchase up to ... 
Printer Friendly Version
04/29/10PhotoMedex Launches New Corporate Website
Redesign focuses on Company's commitment to the Science of Skin Health MONTGOMERYVILLE, Pa., Apr 29, 2010 (BUSINESS WIRE) --PhotoMedex, Inc. (NASDAQ:PHMD), a global skin health medical technology company, announced today the launch of its newly designed and engineered website. The redesigned site, www.photomedex.com, integrates a strong new corporate brand identity with an unmatched commitment to skin care scientific development. PhotoMedex is a glob... 
Printer Friendly Version
02/03/10PhotoMedex Announces Results of Special Meeting of Stockholders
MONTGOMERYVILLE, Pa., Feb 03, 2010 (BUSINESS WIRE) -- PhotoMedex, Inc. (Nasdaq: PHMD) announced the results of its Special Meeting of Stockholders held on February 3, 2010, at the offices of Morgan, Lewis & Bockius LLP, 1701 Market Street, Philadelphia, PA 19103. The following matters were approved by the Company's stockholders at the Special Meeting: A reverse stock split of the Company's issued and outstanding shares of common stock at an exchange ratio of 1-for-6 and authorization... 
Printer Friendly Version
01/21/10PhotoMedex Regains Nasdaq Compliance
MONTGOMERYVILLE, Pa., Jan 21, 2010 (BUSINESS WIRE) -- PhotoMedex, Inc. (Nasdaq:PHMD) today announced that it has regained compliance with the minimum bid price requirement of The Nasdaq Stock Market under Nasdaq Listing Rule 5450(a)(1). On September 15, 2009, Nasdaq notified the Company that its common stock had failed to maintain a minimum bid price of $1.00 for the previous 30 consecutive business days as required by the Nasdaq Listing Rules. Nasdaq has informed the Company that for the last... 
Printer Friendly Version
01/11/10PhotoMedex and Galderma to Co-Promote Actinic Keratosis Treatment
MONTGOMERYVILLE, Pa., Jan 11, 2010 (BUSINESS WIRE) -- PhotoMedex (Nasdaq: PHMD) and Galderma Laboratories, L.P. have entered into a co-promotion agreement for Galderma's photodynamic therapy application for the treatment of actinic keratoses ("AK"). Under the terms of the agreement, PhotoMedex' sales force will promote Galderma's drug Metvixia(R) (methyl aminolevulinate) Cream, 16.8% ("Metvixia") and Galderma's Aktilite(R) CL128 LED (light-emitting diode) lamp to healthcare professionals, includ... 
Printer Friendly Version